Anti‐idiotypic antibodies as molecular mimics of conserved influenza hemagglutinin epitopes
Protein Science · 2026
DOI: 10.1002/pro.70795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, 2026. Verfasst von Hiroshi Itou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chiome Bioscience Inc., Tokyo, Japan. Hauptthemen laut MEDLINE: Epitopes, Hemagglutinin Glycoproteins, Influenza Virus, Molecular Mimicry, Antibodies, Anti-Idiotypic. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health, Labour and Welfare, Japan Agency for Medical Research and Development, Japan Science and Technology Agency.
Abstract (Originalsprache)
Broadly neutralizing antibodies (bNAbs) provide insights for developing universal influenza vaccines through their ability to neutralize diverse viral strains. However, designing antigens that reliably elicit bNAb responses remains challenging due to the difficulty in targeting conserved epitopes with a single antigen. We developed a method using anti‐idiotypic antibodies (IDs) to generate antigens that induce cross‐reactive antibodies against diverse influenza A and B hemagglutinins. Our approach leverages IDs that mimic the conformational epitopes targeted by bNAbs. Structural analysis reveals conformational similarity between bNAb–ID and bNAb–HA‐binding interfaces, providing mechanistic insight into molecular mimicry. These epitope‐mimicking IDs function as effective immunogens, inducing highly cross‐reactive antibodies. This study demonstrates the feasibility and structural basis of molecular mimicry‐based antigen design for targeting conserved conformational epitopes. Although these findings establish proof of concept, vaccine applicability requires further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chiome Bioscience Inc., Tokyo, Japan.
- Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
- Institute for Vaccine Research and Development, Hokkaido University, Hokkaido, Japan.
- Department of Infections Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
- Department of Virus Research, Kyoto University, Kyoto, Japan.
- Department of Infectious Disease Pathobiology, Graduate School of Medicine, Chiba University, Chiba, Japan.
ORCID-Profile: Hiroshi Itou, Kaori Sano, Kazushige Otsuki, Toshikazu Inoue, Takuya Hemmi, Tadaki Suzuki
Förderung
- Ministry of Health, Labour and Welfare
- Japan Agency for Medical Research and Development
- Japan Science and Technology Agency
Zitieren
APA
Itou, H., Sano, K., Ainai, A., Otsuki, K., Inoue, T., Hemmi, T., Hasegawa, H., & Suzuki, T. (2026). Anti‐idiotypic antibodies as molecular mimics of conserved influenza hemagglutinin epitopes. Protein Science. https://doi.org/10.1002/pro.70795
Vancouver
Itou H, Sano K, Ainai A, Otsuki K, Inoue T, Hemmi T, et al. Anti‐idiotypic antibodies as molecular mimics of conserved influenza hemagglutinin epitopes. Protein Science. 2026. doi:10.1002/pro.70795
BibTeX
@article{Itou2026,
author = {Itou, Hiroshi and Sano, Kaori and Ainai, Akira and Otsuki, Kazushige and Inoue, Toshikazu and Hemmi, Takuya and Hasegawa, Hideki and Suzuki, Tadaki},
title = {Anti‐idiotypic antibodies as molecular mimics of conserved influenza hemagglutinin epitopes},
journal = {Protein Science},
year = {2026},
doi = {10.1002/pro.70795}
}
EUVIMED